GlassScriptPhysician profile
Ian Guzy
NPI 1265988844
$1,814.37
in general payments reported to CMS, 2019-2025
8 companies · $1,152 in 2025
The $1,152 reported for 2025 was more than what 96% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $79.22 · 2023: $135 · 2024: $448 · 2025: $1,152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Education: $364 · Gift: $11.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.42 |
| Education | $363.93 |
| Gift | $11.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,341.48 | 2024-2025 | Invisalign |
| Nobel Biocare USA | $186.51 | 2022-2023 | Nobelactive |
| Zest Holdings, LLC | $161.58 | 2024 | |
| Solventum Corporation | $55.86 | 2025 | 3m Scotchbond, 3m Clinpro |
| Revance Therapeutics, INC. | $27.40 | 2025 | Daxxify |
| Envista Holdings Corporation | $14.07 | 2024 | Maxcem Elite |
| Gc America INC. | $13.93 | 2023 | G-Aenial |
| Elevate Oral Care | $13.54 | 2023 | Just Right 5000, Fluorimax 5000, Fluorimax Mint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Guzy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.